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General Directions 
Solvents and Reagents: Solvents were dried as follows: MeCN and CH2Cl2 were distilled 
over CaH2. Alternatively MeCN and CH2Cl2 were dried and deoxygenated with Grubbs-type 
solvent purification system. The moisture content of the solvents was monitored by Karl 
Fischer coulometric titration. Reagents were used as commercially supplied unless otherwise 
stated  and  handled  in  accordance  with  COSHH  regulations.
1 Microwave Irradiation: These were performed on a Biotage Initiator microwave reactor 
with  the  temperature  determined  by  IR.  Chromatography:  Flash  chromatography  was 
performed on silica gel (60 F254, 230-400 mesh) according to the method of W.C. Still.
2 Pre-
packed fluorous solid-phase extraction (F-SPE)  cartridges were purchased from  Fluorous 
Technologies Inc. and pre-conditioned with 50:50 MeCN-H2O. Crude reaction mixtures were 
loaded on the cartridge using CH2Cl2 and eluted with MeCN-H2O (1:1) as the fluorophobic 
eluant. Thin layer chromatography (TLC) was performed on aluminium plates pre-coated 
with silica (60 F254, 0.2 mm) which were developed using standard visualising agents: ultra 
violet  fluorescence  (254  nm),  KMnO4/Δ  or  vanillin/Δ. 
1H  NMR  Spectra:  These  were 
recorded at 500, 400 or 300 MHz. Chemical shifts (δH) are quoted in parts per million (ppm) 
referenced to the appropriate residual solvent peak, with the abbreviations s, d, t, and m 
denoting singlet, doublet, triplet and multiplet respectively. 
13C NMR Spectra: These were 
recorded at 125, 100 or 75 MHz. Chemical shifts (δC) are quoted in parts per million (ppm) 
referenced  to  the  appropriate  residual  solvent  peak,  with  the  abbreviations  s,  d,  t,  and  q 
denoting C, CH, CH2 and CH3 respectively. No attempt was made to resolve the chemical 
shifts of carbons on the fluorous-tag by applying fluorine-decoupling at δ -125.1 ppm during 
acquisition; these carbons are not reported. 
19F NMR spectra: These were recorded at 367 
MHz. Chemical shifts (δF) are given in parts per million (ppm) as referenced to CFCl3. Infra 
Red Spectra: These were recorded as thin films or as solids. Only selected absorbencies 
(νmax) are reported.  Mass Spectra: Molecular ions and major peaks only are reported for low 
resolution spectra. Intensities are given as percentages of the base peak. HRMS values are 
valid to 5 ppm. Optical Rotations: These were recorded on a Perkin-Elmer 241 polarimeter 
at 589 nm (Na D-line) with a path length of 1 dm. Concentrations (c.) are quoted in g/100 mL 
and  specific  rotations,  [ʱ]D
T,  are  quoted  in  units  of  10
-1  deg  cm
2  g
-1
  at  the  specified 
temperature, T. CD Spectra: These were recorded in MeOH with a Jasco J-715 using 10 mm 
quartz cuvettes. UV Spectra: These were extracted from the corresponding HPLC UV diode 
                                                 
1 http://www.hse.gov.uk/coshh/index.htm. 
2 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923. 2 
array detector (DAD) data. Melting Points: Analyses were carried out using a hot-stage and 
are uncorrected. 3 
 
General Procedure for Screening of Conditions for Palladium-Mediated Biaryl Ether 
Formation (Table 1). 
 
Entry  Pd Source 
(mol%) 
Base (eq.)  Ligand 
(mol%) 
T (
oC)  Outcome
a (20:22:21) 
1
3  Pd(OAc)2 (2)  NaH (1.4)  L1 (3)  100  1:0:0a 
2
 3  Pd(OAc)2 (2)  K3PO4 (2.0)  L1 (3)  100  5.7:0:1 (15% conv.)a 
3
 3  Pd(OAc)2 (2)  Na salt 19 (1.2)  L1 (3)  110a  1:0:0 
4
 3  Pd2(dba)3 (1.2)  Na salt 19 (1.2)  L1 (3.75)  110a  1:0:0 
5
 3  Pd(OAc)2 (4)  NaH (2.2)  L1 (6)  115a  1:0:1.4  (58% conv.) 
6
 3  Pd(OAc)2 (2)  NaH (1.4)  L2 (3)  100a  1:0:0 
7
 3  Pd(OAc)2 (2)  K3PO4 (2.0)  L2 (3)  100a  9:0:1 (10% conv.) 
8
 3  Pd(OAc)2 (2)  Na salt 19 (1.2)  L2 (3)  110a  1:0:0 
9
 3  Pd2(dba)3 (1.2)  Na salt 19 (1.2)  L2 (3)  110a  5.7:0:1 (15% conv.) 
10
 3  Pd(OAc)2 (4)  NaH (2.2)  L2 (6)  115a  1:0:2.5 (71% conv.) 
11
 4  Pd(OAc)2 (2)  K3PO4 (2.0)  L5 (4)  120a  1.5:0:1 (40% conv.) 
12
 5  Pd(OAc)2 (3)  K3PO4 (2.0)  L4 (5)  110a  1:0:1.5 (60% conv.) 
13
 5  Pd(OAc)2 (3)  K3PO4 (2.0)  L3 (5)  110a  1:0:2.5 (71% conv.) 
Table 1: Investigation of Pd-catalysed biaryl ether formation.  Reagents and conditions: as above, 60 h, N2 
atmosphere, toluene, 0.25 mmol.  
a Determined by 
1H NMR analysis of the unpurified reaction mixture. 
An oven-dried reaction vial was charged with a stirrer bar, aryl bromide 20, base, phenol 19, 
palladium catalyst and ligand.  The vial was equipped with a Suba-seal, then respectively 
evacuated and purged with nitrogen (× 5) before addition of toluene. 
The Suba-seal was replaced by a screw cap under a flow of nitrogen, and the reaction mixture 
was heated at the appropriate temperature for the desired time.  After this time the reaction 
was  allowed  to  cool  to  r.t.,  filtered  through  a  pad  of  Celite
,  washed  with  acetone  and 
concentrated in vacuo.  Integration of key peaks in the 
1H NMR spectra of the unpurified 
reaction  mixtures  was  used  to  determine  the  product  distribution.
                                                 
3 Aranyos, A.; Old, D. W.; Kiyomori, A.; Wolfe, J. P.; Sadighi, J. P.; Buchwald, S. L. J. Am. Chem. Soc. 1999, 
121, 4369-4378. 
4 Harkal, S.; Kumar, K.; Michalik, D.; Zapf, A.; Jackstell, R.; Rataboul, F.; Riermeier, T.; Monsees, A.; Beller, 
M. Tetrahedron Lett. 2005, 46, 3237-3240. 
5 Burgos, C. H.; Barder, T. E.; Huang, X.; Buchwald, S. L. Angew. Chem. Int. Ed. 2006, 45, 4321-4326. 4 
 
General  Procedure  for  Screening  of  Conditions  for  Copper-Mediated  Biaryl  Ether 
Formation (Table 2) 
 
Entry   19 
eq. 
Cu Source 
 (mol%) 
Base 
(eq.) 
Solvent  Additive 
(mol%) 
T 
(
oC) 
Outcome
a  
20:22:21 
% Conversion
 
(% 22)
a 
1
6  1.2  CuI  
(10) 
K2CO3 
(2.0) 
1,4-dioxane  Ni-Al alloy 
(30)a 
110  2:5:1  75 (63) 
2
7  1.4  (CuOTf)2∙PhH 
(2.5) 
Cs2CO3 
(1.4) 
toluene  EtOAc (5)  110  0:1:0  >98 (>98) 
72% isolated 
yielda 
3
8  1.5  Cu2O  
(10) 
Cs2CO3 
(2.0) 
MeCN  L1 (20)  110  0:>20:1  >98 (98) 
70% isolated 
yielda 
4
9  1.5  CuI  
(10) 
Cs2CO3 
(2.0)a 
1,4-dioxane  L2 (30)  90  3:10:1  79 (71) 
5
10  2.0  CuCl  
(50) 
Cs2CO3 
(2.0)A 
NMP  L3 (10)  120  0:18:1  100 (95) 
6
11  2.0  CuCl  
(50) 
Cs2CO3 
(2.0)a 
NMP  L4 (10)  120  0:>20:1  100 (98) 
Table 2: Ullmann-type copper catalysed biaryl ether formation.  Reagents and conditions: as above, 60 h, N2 atmosphere, 
0.25 mmol. 
aDetermined by 
1H NMR analysis of the unpurified reaction mixture. 
An oven-dried reaction vial was charged with a stirrer bar, aryl bromide 20, base, phenol 19, 
copper salt and additive/ligand.  The vial was equipped with a Suba-seal, then repeatedly 
evacuated and purged with nitrogen (× 5) before addition of the solvent. The Suba-seal was 
then replaced by a screw cap under a flow of nitrogen, and the reaction mixture was heated at 
the appropriate temperature for the desired time.  After this time the reaction was allowed to 
cool to r.t., filtered through a pad of Celite
, washed with acetone and concentrated in vacuo.  
In  the  case  of  reactions  carried  out  in  DMA  as  solvent,  the  crude  reaction  mixture  was 
flushed through a silica plug with EtOAc:petrol (1:5) and concentrated in vacuo.  Integration 
of  key  peaks  in  the 
1H  NMR  spectra  of  the  unpurified  reaction  mixtures  was  used  to 
determine the product distribution. 
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NMR Spectra for compounds 8, 12, 13, 14, 17a, 22, 28, 4b, 5, 30 and 31. 
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1 H NMR, 500 MHz, CDCl3 
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1H NMR, 400 MHz, CDCl3 
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1H NMR, 400 MHz, CDCl3 
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HSQC NMR, CDCl3 
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1H NMR, 400 MHz, CDCl3 
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1H NMR, 400 MHz, CDCl3 
 
 
13C NMR, 125 MHz, CDCl3 
 14 
1H NMR, 400 MHz, CDCl3 
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19F NMR, 376 MHz, CDCl3 
 
 
19F COSY NMR, CDCl3 
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19F NMR, 376 MHz, CDCl3 
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1H NMR, 400 MHz, CDCl3 
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19F NMR, 376 MHz, CDCl3 
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1H NMR, 400 MHz, CDCl3 
 
 
13C NMR, 100 MHz, CDCl3 
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1H NMR, 400 MHz, CDCl3 
 
 
13C NMR, 100 MHz, CDCl3 
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1H NMR, 400 MHz, CDCl3 
 
 
13C NMR, 100 MHz, CDCl3 
 24 
HPLC Separation of enantiomers of aspercyclide A C19 methyl ether (31) 
Synthetic (±)-aspercyclide A C19 methyl ether, (±)-(31) 
HPLC (CHIRALPAK-IA column, sample conc. 2 mg/mL in CH2Cl2, injection volume 5 µL) 
 
 
Synthetic (–)-aspercyclide A C19 methyl ether, (-)-(31) 
HPLC (CHIRALPAK-IA column, sample conc. 5 mg/mL in CH2Cl2, injection volume 2 µL) 
 25 
UV (n-hexane/i-PrOH, 95:5) 
 
CD (MeOH, 0.02 mg/mL) 
 
Synthetic (+)-aspercyclide A C19 methyl ether, (+)-(31) 
HPLC (CHIRALPAK-IA column, sample conc. 5 mg/mL in CH2Cl2, injection volume 2 µL) 
 26 
UV (n-hexane/i-PrOH, 95:5) 
 
CD (MeOH, 0.02 mg/mL) 
 
Natural (+)-aspercyclide A, (+)-1 
CD (MeOH, 1.0 mg/mL) 
 27 
IgE Receptor Binding Enzyme-linked Immunosorbent Assay (ELISA) 
Compounds were evaluated in a receptor binding ELISA assay using IgE-Fc (Cε2-4) protein, 
a chimeric construct of the ʱ-subunit of FcεRI fused to the Fc region of IgG4 [referred to 
below as AG (alphagamma) receptor protein], Biotinylated anti-IgE (Vector Laboratories), 
Streptavidin-Horse  Radish  Peroxidase  conjugate  (Biosource  International,  Inc.)  and  o-
phenylenediamine dihydrochloride (OPD, Sigma-Aldrich) in P96 Maxisorp NUNC 439454 
Immunoplates (Nalge Europe Ltd.) named ELISA plate.  
The protocol was as follows: The ELISA plate was coated with 100 μL/well of an 2 μg mL
-1 
AG receptor protein solution made up in aqueous carbonate buffer (0.045 M NaHCO3 + 
0.018 M Na2CO3, pH 9.8) then was incubated overnight at 4 °C. After 3 washing steps with 
300 μL/well of PBS, 0.1% Tween 20 v/v for 2-3 min, to remove residual AG protein, the 
unbound sites were blocked by adding 300 μL/well of PBS, 2 % Bovine Serum Albumin 
(BSA) v/v. The plate was then incubated for 1 h at 37 °C. Controls and antagonists’ solutions 
(i.e. compounds (+)-31, (–)-31 and (±)-31) were prepared on a classic clear 96-wells plate 
(NUNC 262162) separately from the ELISA plate. Each well has a total volume of 110 µL 
and a final DMSO concentration of 5% v/v. The antagonists were tested in duplicate from 1 
mM to 30.5 nM final concentrations. First, 180 µL of the 1 mM concentrations were prepared 
in PBS, 5 % DMSO from the 100 mM stock solutions in DMSO, then serial 1/2 dilutions 
were performed by taking 90 µL of each concentration in 90 µL of PBS 5 % DMSO. After 
the last dilution, 90 µL of the solution is removed in order to have 90 µL in all the wells. Six 
different controls named Fc, D, RB, AG, P and W were prepared in triplicate for each plate as 
indicated in the table below. Rose Bengal (Sigma-Aldrich) was used as a control antagonist 
as well as alphagamma. In all the wells except in the P and W controls, were added 20 µL of 
an IgE Fc solution (0.0137 ng/µL in PBS) in order to have a total volume of 110 µL. The 
plate was covered and left at room temperature for a 1 h pre-incubation step. 
 
Controls for 
1 well 
volumes in 
µL 
IgE Fc 
0.0137 ng/µL 
in PBS 
DMSO  Rose Bengal 
10 mM 
DMSO 
Alphagamma 
1.15 mg/mL 
in PBS 
PBS  MilliQ 
water 
Fc  20  -  -  -  90  - 
RB  20  5.39  0.11  -  84.5  - 
AG  20  5.5  -  1  83.5  - 
D  20  5.5  -  -  84.5  - 
P  -  5.5  -  -  104.5  - 
W  -  5.5  -  -  -  104.5 
 28 
The blocked ELISA plate was washed with PBS-Tween 20 (0.1% v/v, 3 × 300 μL/well, 2-3 
min) then 100 μL/well were transferred from the  pre-incubated plate to the ELISA plate 
keeping to the same template. The ELISA plate was then incubated for 1 h at 37 °C to allow 
the binding of IgE to its receptor. The plate was washed with PBS-Tween 20 (0.1% v/v, 3 × 
300 μL/well) with a first washing step of 30 min, then 2-3 minutes for the 2 others washing 
steps in order to ensure the removal of the compounds. Bound IgE-Fc was detected by adding 
100 μL/well of biotinylated anti-IgE (1/5000 dilution in PBS, 1% v/v BSA), then the plate 
was incubated for 1 h at 37 °C. After 3 washing steps with PBS-Tween 20 (0.1% v/v, 300 
μL/well, 2-3 min), 100 μL/well of streptavidin-HRP (1/5000 dilution in PBS, 1% v/v BSA) 
were added. The plate was incubated 1 h at 37 °C, and then washed with PBS (3 × 300 
μL/well, 2-3 min). The HRP substrate solution was prepared by dissolving 1 tablet of OPD in 
9 mL of water and 1 mL of 10X peroxide buffer, then 50 µL/well were added to the plate. 
After 4 min incubation at room temperature in the dark, the enzyme reaction was stopped by 
addition of 50 μL/well of HCl 3 M. Absorbance detection of the plate was then performed at 
492 nm using an ELISA plate reader (Titertek Multiskan).  
All the titrations were performed twice in duplicate. All data were plotted and analyzed using 
Kaleidagraph® software (Synergy Software, Reading, PA). For each well, the percent of 
inhibition was calculated using the following equation (1):  
% inhibition = 100 – ((100*(OD492 nm− μc-) / (μc+ − μc-))          (1) 
in which OD492 nm is the absorbance measured at 492 nm; μc- is the average of the negative 
control P (100% inhibition); μc+ is the average of the positive control D (0% inhibition). 
To obtain the inhibition curves, the logarithms of each compounds concentration were plotted 
versus the average inhibition percentages obtained for each concentration. The data were 
fitted using the sigmoidal equation (2): 
Y = (100 * x)
b/(C
b + x
b)                   (2) 
where x = Log [concentration µM], b = Hill number; C = IC50. 29 
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